We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Drug Assay Technology Licensed

By HospiMedica staff writers
Posted on 06 Jun 2002
An exclusive license to a recently issued US patent for methods relating to the measurement of electrical waveforms of tissue or cells has been obtained by Tensor Biosciences (Irvine, CA, USA) from Matsushita Electric Industrial Co, Ltd. More...
(Osaka, Japan). Tensor will apply the new technology to the development of in vitro drug screening assays.

Tensor has combined computer science and multi-electrode neurophsyiology to develop more predictive technology for discovering neurotherapeutics. The company has various patents on methods for testing drugs on slices of living brain tissue. The technology described in the new patent relates to Tensor's advanced brain slice culture methods and their application to multisite electrophysiology. Applications could include drug candidate characterization, development of in vitro models of psychiatric and neurodegenerative disorders, and rapid on-site testing of chronic drug toxicities and side effects on networks of neurons, revealing lethal and nonlethal drug effects for up to three weeks.

"In close partnership with Matsushita and the University of California at Irvine, we have now pioneered a method for measuring long-term drug effects on living brain tissue,” said Dr. James Whitson, president and CEO of Tensor.




Related Links:
Tensor Biosciences

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Platelet Function Analyzer
PL-12
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.